Zacks Research Expects Weaker Earnings for Tenet Healthcare

Tenet Healthcare Co. (NYSE:THC) – Stock analysts at Zacks Research decreased their Q4 2024 earnings estimates for Tenet Healthcare in a research report issued to clients and investors on Wednesday, December 18th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $2.87 for the quarter, down from their previous estimate of $2.88. The consensus estimate for Tenet Healthcare’s current full-year earnings is $11.38 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q2 2025 earnings at $2.66 EPS, Q4 2025 earnings at $3.20 EPS and Q1 2026 earnings at $3.45 EPS.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $2.33 by $0.60. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. The company had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.05 billion. During the same period in the previous year, the firm earned $1.44 earnings per share. The firm’s quarterly revenue was up 1.1% on a year-over-year basis.

A number of other research firms also recently issued reports on THC. Barclays boosted their target price on shares of Tenet Healthcare from $171.00 to $190.00 and gave the company an “overweight” rating in a research report on Friday, November 8th. UBS Group boosted their price target on shares of Tenet Healthcare from $197.00 to $217.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. KeyCorp started coverage on shares of Tenet Healthcare in a report on Friday, October 11th. They set an “overweight” rating and a $200.00 price objective for the company. Royal Bank of Canada raised their price target on shares of Tenet Healthcare from $174.00 to $183.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Finally, JPMorgan Chase & Co. restated an “overweight” rating and issued a $175.00 target price on shares of Tenet Healthcare in a report on Tuesday, December 17th. Three equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $166.88.

Tenet Healthcare Stock Up 0.1 %

Shares of NYSE:THC opened at $129.71 on Monday. The business’s 50-day moving average is $148.61 and its 200-day moving average is $149.17. Tenet Healthcare has a 1 year low of $73.21 and a 1 year high of $171.20. The company has a market capitalization of $12.34 billion, a price-to-earnings ratio of 4.16, a P/E/G ratio of 0.61 and a beta of 2.06. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.58 and a quick ratio of 1.52.

Insiders Place Their Bets

In other Tenet Healthcare news, EVP Lisa Y. Foo sold 4,000 shares of the stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $155.94, for a total transaction of $623,760.00. Following the sale, the executive vice president now owns 15,566 shares in the company, valued at $2,427,362.04. This represents a 20.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.93% of the company’s stock.

Institutional Trading of Tenet Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Plato Investment Management Ltd bought a new stake in shares of Tenet Healthcare during the third quarter valued at about $28,000. ORG Wealth Partners LLC purchased a new position in Tenet Healthcare during the third quarter valued at approximately $30,000. Financial Management Professionals Inc. lifted its stake in Tenet Healthcare by 2,222.2% in the 3rd quarter. Financial Management Professionals Inc. now owns 209 shares of the company’s stock worth $35,000 after purchasing an additional 200 shares in the last quarter. Innealta Capital LLC bought a new position in Tenet Healthcare in the 2nd quarter valued at $28,000. Finally, True Wealth Design LLC bought a new position in shares of Tenet Healthcare in the third quarter worth $38,000. 95.44% of the stock is currently owned by institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.